期刊文献+

宫颈上皮内瘤变患者高危型人乳头状瘤病毒感染与吲哚胺2,3-二氧酶表达的关系 被引量:2

Relation between infection of high-risk human papilloma virus and expression of indoleamine 2,3-dioxy-genase in cervical intraepithelial neoplasia
暂未订购
导出
摘要 目的:研究高危型人乳头状瘤病毒与吲哚胺2,3-二氧酶在宫颈上皮内瘤变组织中表达情况。方法:采用第二代杂交捕获法检测高危型HPV,免疫组化法检测吲哚胺2,3-二氧酶表达。结果:高危型HPV感染与吲哚胺2,3-二氧酶同时阳性的患者占62.91%(95例/151例),同时阴性的患者占21.85%(33例/151例)。高危型HPV感染阳性的患者宫颈组织中吲哚胺2,3-二氧酶阳性表达率显著高于高危型HPV感染阴性患者(χ2=62.1833,P<0.01)。高危型HPV与吲哚胺2,3-二氧酶表达有相关性(r=0.9611,P<0.05)。结论:高危型HPV联合吲哚胺2,3-二氧酶在宫颈上皮内瘤变的疾病发生、发展过程中起到重要作用。 Objectives: To study the expression of high - risk human papilloma virus ( HR - HPV) and in- doleamine 2,3 -dioxygenase (IDO) in cervical intraepithelial neoplasia (CIN). Method: HR- HPV was detected by second- generation hybrid capture. IDO was detected by immunohistochemistry. Results: HR- HPV infection and IDO positive patients accounted for 62.91% (95/151 ), while negative patients accounted for 21.85% (33/ 151 ). The expression of IDO in HR - HPV positive patients was significantly higher than that in HR - HPV negative patients (χ2 =62. 1833, P 〈0.01 ). The overexpression of IDO was positively correlated with HR- HPV infection in CIN (r =0.9611, P 〈0.05). Conclusion: HR- HPV and IDO play an important role in the development of CIN.
作者 廖琪
出处 《中国性科学》 2014年第1期41-43,共3页 Chinese Journal of Human Sexuality
基金 黑龙江省卫生厅支撑项目(2011-622)
关键词 宫颈上皮内瘤变 高危型人乳头状瘤病毒 吲哚胺2 3-二氧酶 Cervical intraepithelial neoplasia High - risk human papilloma virus Indoleamine 2,3 - dioxygenase
  • 相关文献

参考文献15

  • 1乐杰.妇产科学[M]{H}北京:人民卫生出版社,2007261-263.
  • 2芮平.HPV-DNA亚型检测联合液基细胞学对宫颈癌筛查的临床价值[J].中国性科学,2012,21(7):48-50. 被引量:45
  • 3Wu R,Belinson SE,Du H. Human papillomavirus messenger RNA assay for cervical cancer screening:the Shenzhen Cervical Cancer Screening Trial I[J].{H}International Journal of Gynecological Cancer,2010,(08):1411-1414.
  • 4郑占才,张晓宁,赵华英,陈颖.重组人干扰素肌注与干扰素阴道栓联合使用治疗宫颈高危型HPV感染[J].中国性科学,2011,20(10):10-11. 被引量:13
  • 5Moffett JR,Namboodiri MA. Tryptophan and the immune response[J].{H}Immunology and Cell Biology,2003,(81):247-265.
  • 6Shirey KA,Jung JY,Maeder GS. Upregulation of IFN-γreceptor expression by proinflammatory cytokines Influences IDO activation in epithelial cells[J].{H}Journal of Interferon and Cytokine Research,2006,(01):53-62.
  • 7Sucher R,Fischler K,Oberhuber R. IDO and regulatory T cell supper are critical for cytotoxic T lymphocyte-associated Ag-4 long-term solid organ allograft survival[J].{H}Journal of Immunology,2012,(188):37-46.
  • 8Munn DH,MellorAL. Indoleamine 2,3-dioxygenase and tumor-induced tolerance[J].JC lin Invest,2007,(05):1147-1154.
  • 9Brody JR,Costantino CL,Berger AC. Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survival[J].{H}CELL CYCLE,2009,(08):1930-1934.
  • 10Hiroaki Nonaka,Yasushi Saga,Hiroyuki Fujiwara. Indoleamine2,3-dioxygenase promotes peritoneal dissemination of ovarian cancer through inhibition of natural killercell function and angiogenesis promotion[J].Inter Oncology,2011,(38):113-120.

二级参考文献16

  • 1Belinson,SE.; Belinson,JL.Human Papillomavirus DNA Testing for Cervical Cancer Screening:Practical Aspects in Developing Countries[J].Molecular Diagnosis & Therapy.2010,14(4):215-222.
  • 2Tarkkanen J,Auvinen E,Nieminen P,et al.HPV DNA testing as an adjunct in the management of patients with low grade cytological lesions in Finland[J].Acta Obstet Cynecol Scan,2007,86(3):367-372.
  • 3Coquillard G, Palao B, Patterson BK. Quantification of in- tracellular HPV E6/E7 mRNA expression increases the specificity and positive predictive value of cervical cancer screening compared to HPV DNA. Gynecol Oncol,2011, 120(1) :89-93.
  • 4Janssen PG, Boomsma LJ, Buis PA, et al. Summary of the practice guideline Prevention and early diagnosis of cervical cancer'of the Dutch College of General Practitioners. Ned Tijdschr Geneeskd ,2009, (153) :A1517.
  • 5Wu R, Belinson SE, Du H, et al. Human papillomavirus messenger RNA assay for cervical cancer screening: the Shenzhen Cervical Cancer Screening Trial I. Int J Gynecol Cancer,2010, 20 (8) : 1411 - 1414.
  • 6Matsuura Y, Kawagoe T, Toki N, et al. Uterine cervical cancer screening in Japan: today and future. J UOEH, 2009, 31(2) :181 -193.
  • 7Saraiya M, Irwin KL, Carlin L, et al. Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Pro- gram (NBCCEDP) . Cancer,2007, 110(5) :1024 - 1032.
  • 8张利萍,张滨,侯云德.七 干扰素治疗人乳头瘤病毒感染及其他病毒病[J].中华实验和临床病毒学杂志,2008,22(2):156-160. 被引量:2
  • 9陈文兵,郭巧燕,张海燕,蔡莲莲,吕杰强,王乐丹,郑小东.HPV、CT感染与HSP60在子宫颈癌及癌前病变组织中表达的关系[J].实用肿瘤杂志,2008,23(3):266-269. 被引量:4
  • 10刘红卫,李亚芙.高危型HPV检测联合液基细胞学在宫颈癌前病变筛查中的应用[J].陕西医学杂志,2010,39(6):674-675. 被引量:22

共引文献54

同被引文献19

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部